Regulatory Pathway for Licensing Biotherapeutics in Mexico.
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 27 de febrero de 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Colloids and Surfaces A: Physicochemical and Engineering Aspects. Structural and physicochemical characteristics of one-step PAMAM dendrimeric nanoparticles. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection....
-
UDIBI
admin_udibi3, , 2023, Sin categorizar, 0
Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 20 de marzo del 2021 Consistency of a dialyzable leucocyte extract manufactured at GMPfacilities by Nuclear...